Viruses (Jun 2024)

Torquetenovirus Viremia Quantification Using Real-Time PCR Developed on a Fully Automated, Random-Access Platform

  • Pietro Giorgio Spezia,
  • Fabrizio Carletti,
  • Federica Novazzi,
  • Eliana Specchiarello,
  • Angelo Genoni,
  • Francesca Drago Ferrante,
  • Claudia Minosse,
  • Giulia Matusali,
  • Nicasio Mancini,
  • Daniele Focosi,
  • Guido Antonelli,
  • Enrico Girardi,
  • Fabrizio Maggi

DOI
https://doi.org/10.3390/v16060963
Journal volume & issue
Vol. 16, no. 6
p. 963

Abstract

Read online

Quantification of Torquetenovirus (TTV) viremia is becoming important for evaluating the status of the immune system in solid organ transplant recipients, monitoring the appearance of post-transplant complications, and controlling the efficacy of maintenance immunosuppressive therapy. Thus, diagnostic approaches able to scale up TTV quantification are needed. Here, we report on the development and validation of a real-time PCR assay for TTV quantification on the Hologic Panther Fusion® System by utilizing its open-access channel. The manual real-time PCR previously developed in our laboratories was optimized to detect TTV DNA on the Hologic Panther Fusion® System. The assay was validated using clinical samples. The automated TTV assay has a limit of detection of 1.6 log copies per ml of serum. Using 112 samples previously tested via manual real-time PCR, the concordance in TTV detection was 93% between the assays. When the TTV levels were compared, the overall agreement between the methods, as assessed using Passing–Bablok linear regression and Bland–Altman analyses, was excellent. In summary, we validated a highly sensitive and accurate method for the diagnostic use of TTV quantification on a fully automated Hologic Panther Fusion® System. This will greatly improve the turnaround time for TTV testing and better support the laboratory diagnosis of this new viral biomarker.

Keywords